In 2007 Dr. Younes talked about the "need for not only more effective treatment, but safer treatment" for
Hodgkin's Lymphoma patients.
Over the last few years there have been significant changes in the treatment of patients with
Hodgkin's lymphoma. According to Younes "Ten years ago phase one trials were designed to just see how well the patient could tolerate the drugs." Currently available clinical trials is they are more rationally designed. Today even in phase one clinical trials, it is expected that patients will see benefit from these treatments.
Link to this comment:
All Comments (0)